Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
Nigel G. Kooreman1,2,3, Youngkyun Kim1,2,4,5, Patricia E. de Almeida1,2,6, Vittavat Termglinchan1,2,4, Sebastian Diecke7,8,9, Ning-Yi Shao1,2,4, Tzu-Tang Wei1,2,6, Hyoju Yi1,2,5, Devaveena Dey1,2,4, Raman Nelakanti1,2,4, Thomas P. Brouwer1,2,4,3, David T. Paik1,2,4, Idit Sagiv-Barfi10, Arnold Han11,12,13, Paul H.A. Quax3, Jaap F. Hamming3, Ronald Levy10, Mark M. Davis11,12,13, Joseph C. Wu1,2
1Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
2Stanford Cardiovascular Institute of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Surgery, Leiden University Medical Center, Leiden 2333 ZA, the Netherlands
4Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305 USA
5Convergent Research Consortium for Immunologic Disease, Seoul St. Mary’s Hospital, Catholic University of Korea, Seoul 06591, Korea
6Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA
7Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rossle Strasse 10, 13125 Berlin, Germany
8DZHK (German Centre for Cardiovascular Research), partner site, Berlin, Germany
9Berlin Institute of Health (BIH), Berlin, Germany
10Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA
11Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA
12Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305 USA
13The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Cell Stem Cell
Tập 22
501-513.e7
Thông tin tác giả